Hikal Ltd. News and Updates

Name: Latest research reports of Hikal Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Hikal Ltd.
Rating: 3
Author: ICICI Direct

Keep track of all breaking news on Hikal Ltd. from all sources in a single place.

Load latest

Hikal Ltd.

07 Aug 2023

416.75

-0.04%

Hikal share price rises nearly 2% after GPCB withdrawn closure order

Moneycontrol

The share touched a 52-week high of Rs 427.95 and a 52-week low of Rs 244.95 on 03 January, 2023 and 11 August, 2022, respectively.

Hikal Ltd. is trading above all available SMAs

Hikal Ltd.

24 Jul 2023, 09:55AM

416.75

-0.04%

Hikal down over 5% after Gujarat pollution board orders closure Bharuch unit

Moneycontrol

The company says it commitment to environmental norms remains unwavering and it is engaging with the pollution board to resolve the matter

Hikal Ltd. has gained 32.01% in the last 1 Year

Hikal Ltd.

02 Jun 2023

416.75

-0.04%

Broker's Call: Hikal Ltd (Buy)

Business Line

ULJK Financial Services

Hikal Ltd. has an average target of 420.00 from 1 broker.

Hikal Ltd.

30 May 2023

416.75

-0.04%

Hikal Ltd's shares surge 11% on robust Q4 numbers

Moneycontrol

The agrochemicals and pharmaceutical company reported a 74 percent YoY growth in net profit, amounting to Rs 36 crore for Q4FY23. Sequentially, the net profit grew by 37 percent in Q4 FY23, driven by a better product mix.

Hikal Ltd. has an average target of 420.00 from 1 broker.

Hikal shares surge 12% after Q4 numbers; details here

livemint | 30 May 2023 1 more

Hikal Ltd.

30 May 2023

416.75

-0.04%

Hikal Ltd

Hold: Hikal Ltd.

Target

ICICI Direct

Hikal Ltd. has gained 32.01% in the last 1 Year

Hikal Ltd.

29 May 2023

416.75

-0.04%

to see Rapid results content

Hikal Ltd.

18 May 2023

416.75

-0.04%

Dispute between two promoters not to impact corporate performance: Hikal

Business Standard

Pharmaceuticals and crop protection firm Hikal Ltd on Thursday refuted allegations by proxy advisory firm InGovern Research Services that the battle between its two promoters is impacting corporate performance. Hikal is in the midst of a battle between two promoter groups -- the Hiremaths who own 34.84 per cent stake and Baba N Kalyani (BNK)-led side that holds 34.01 per cent of the company. Minority shareholders own 31.15 per cent. InGovern in a note to shareholders had stated that in the absence of an agreement between the two warring promoter groups due the proportion of shareholding makes it difficult for any special resolution to be passed. It was also likely to slow down decision-making and resultantly, the interest of the company is likely to be compromised. In a detailed response to points raised by InGovern, Hikal said, "The document is a one-sided and an ill-informed attempt to damage the credibility of the company and its management and has been made with the intention of

Hikal Ltd. is trading above all available SMAs

Hikal Ltd.

14 May 2023

416.75

-0.04%

Future of pharma company Hikal at risk due to warring promoters, warns independent advisory firm InGovern

Business Line

Proxy advisory firm seeks new MD to manage day-to-day affair; fate of the 75,000 shareholders of Hikal hangs in balance as the company operates in a highly competitive sector